Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Rubie, Claudia ^a   Kruse, Bianca ^a   Frick, Vilma O ^a   Kölsch, Kathrin ^a   Ghadjar, Pirus ^b   Wagner, Mathias ^a   Grässer, Friedrich ^a   Wagenpfeil, Stefan ^a   Glanemann, Mathias ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CCR6; Chemokine receptors; CRC; microRNA; miR 518a 5p

Indexed keywords

CHEMOKINE RECEPTOR CCR6; LUCIFERASE; MICRORNA; MICRORNA 518A 5P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CCR6 GENE; CELL STRAIN CACO 2; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE TARGETING; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUCIFERASE ASSAY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN BINDING; RECEPTORS, CCR6; RNA, MESSENGER; TRANSFECTION;

EID: 84899480846     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-48     Document Type: Article

References (49)

1. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011, 12:99-110. 10.1038/nrg2936, 21245828.
2. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655. 10.1016/j.cell.2009.01.035, 2675692, 19239886.
3. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
4. Wu L, Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNA s and siRNAs. Mol Cell 2008, 29:1-7. 10.1016/j.molcel.2007.12.010, 18206964.
5. Baer C, Claus R, Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 2013, 73:473-477. 10.1158/0008-5472.CAN-12-3731, 23316035.
6. Grund SE, Polycarpou-Schwarz M, Luo C, Eichmüller SB, Diederichs S. Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells. Neoplasia 2012, 14:238-248. 3323901, 22496623.
7. Cowland JB, Hother C, Grønbaek K. MicroRNAs and cancer. APMIS 2007, 115:1090-1106. 10.1111/j.1600-0463.2007.apm_775.xml.x, 18042145.
8. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56. 10.1038/35065016, 11242036.
9. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C, Keilholz U. Chemokine receptor CCR6 expression level and liver metastasis in colorectal cancer. J Clin Oncol 2006, 24:1910-1916. 10.1200/JCO.2005.04.1822, 16622267.
10. Ghadjar P, Rubie C, Aebersold DM, Keilholz U. The chemokine CCR6 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 2009, 125:741-745. 10.1002/ijc.24468, 19480006.
11. Rubie C1, Frick VO, Pfeil S, Wagner M, Kollmar O, Kopp B, Graber S, Rau BM, Schilling MK. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 2007, 13:4996-5002.
12. Rubie C1, Frick VO, Wagner M, Schuld J, Gräber S, Brittner B, Bohle RM, Schilling MK. ELR + CXC chemokine expression in benign and malignant colorectal conditions. BMC Cancer 2008, 8:178-187. 10.1186/1471-2407-8-178, 2459188, 18578857.
13. Rubie C1, Frick VO, Ghadjar P, Wagner M, Justinger C, Faust SK, Vicinus B, Gräber S, Kollmar O, Schilling MK. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells. J Transl Med 2011, 9:22-35. 10.1186/1479-5876-9-22, 3049756, 21349176.
14. Sun W, Julie Li YS, Huang HD, Shyy JY, Chien S. MicroRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng 2010, 12:1-27. 10.1146/annurev-bioeng-070909-105314, 20415587.
15. Rubie C1, Oliveira V, Kempf K, Wagner M, Tilton B, Rau B, Kruse B, Konig J, Schilling M. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 2006, 27:166-174. 10.1159/000092777, 16641550.
16. Frick VO, Rubie C, Kölsch K, Wagner M, Ghadjar P, Graeber S, Glanemann M. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies. Scand J Immunol 2013, [Epub ahead of print].
17. Rubie C, Frick VO, Ghadjar P, Wagner M, Justinger C, Graeber S, Sperling J, Kollmar O, Schilling MK. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J Gastroenterol 2011, 17:3109-3116. 3158410, 21912453.
18. Yang CC, Ogawa H, Dwinell MB, McCole DF, Eckmann L, Kagnoff MF. Chemokine receptor CCR6 transduces signals that activate p130Cas and alter cAMP-stimulated ion transport in human intestinal epithelial cells. Am J Physiol Cell Physiol 2005, 288:321-328.
19. Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Göke B, Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2. SAPK/J. NK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 2006, 97:709-723. 10.1002/jcb.20672, 16215992.
20. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE. The colorectal microRNAome. Proc Natl Acad Sci U S A 2006, 103:3687-3692. 10.1073/pnas.0511155103, 1450142, 16505370.
21. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, García-Foncillas J. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006, 5:29-38. 1550420, 16854228.
22. Vicinus B, Rubie C, Faust SK, Frick VO, Ghadjar P, Wagner M, Graeber S, Schilling MK. miR-21 functionally interacts with the 3′UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells. Cancer Lett 2012, 316:105-112. 10.1016/j.canlet.2011.10.031, 22099878.
23. Vicinus B, Rubie C, Stegmaier N, Frick VO, Kölsch K, Kauffels A, Ghadjar P, Wagner M, Glanemann M. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: Significance of their regulation. Oncol Rep 2013, 30:1285-1292.
24. Bustin SA. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193. 10.1677/jme.0.0250169, 11013345.
25. Rubie C, Kempf K, Hans J, Su T, Tilton B, Georg T, Brittner B, Ludwig B, Schilling M. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005, 19:101-109.
26. Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 2010, 8:29-38.
27. Yi YH, Sun XS, Qin JM, Zhao QH, Liao WP, Long YS. Experimental identification of microRNA targets on the 3′ untranslated region of human FMR1 gene. J Neurosci Methods 2010, 190:34-38. 10.1016/j.jneumeth.2010.04.022, 20435064.
28. Jennewein C, von Knethen A, Schmid T, Brüne B. MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 2010, 285:11846-11853. 10.1074/jbc.M109.066399, 2852921, 20164187.
29. Hutvágner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060. 10.1126/science.1073827, 12154197.
30. Rubie C, Kollmar O, Frick VO, Wagner M, Brittner B, Gräber S, Schilling MK. Differential CXC receptor expression in colorectal carcinomas. Scand J Immunol 2008, 68:635-644.
31. Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, Wang H, Chen J, Wang H. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 2011, 6:19495-19507.
32. Hu D, Du C, Xue W, Dou F, Yao Y, Gu J. The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ-specific for distant metastasis in colorectal cancer: a comparative study. Histopathology 2013, [Epub ahead of print].
33. Slaby O, Svoboda M, Michalek J, Vyzula R. MiRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009, 8:102-114. 10.1186/1476-4598-8-102, 2780389, 19912656.
34. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011, 223:102-115. 10.1002/path.2806, 3069496, 21125669.
35. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. MicroRNA-21 (miR-518a-5p) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136. 10.1038/sj.onc.1210856, 17968323.
36. Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, Worley MJ, Berkowitz RS, Chung TK, Wong YF. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 2012, 11:2876-2884. 10.4161/cc.21278, 22801550.
37. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010, 70:6609-6618. 10.1158/0008-5472.CAN-10-0622, 2922409, 20682795.
38. Grady WM1, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A, Fritz BR, Markowitz SD, Tewari M. Epigenetic silencing of the intronic miRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008, 27:3880-3888. 10.1038/onc.2008.10, 18264139.
39. Liu M1, Lang N, Qiu M, Xu F, Li Q, Tang Q, Chen J, Chen X, Zhang S, Liu Z, Zhou J, Zhu Y, Deng Y, Zheng Y, Bi F. Mir-137 targets cdc42 expression, induces cell cycle g1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer 2011, 128:1269-1279. 10.1002/ijc.25452, 20473940.
40. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F. Mir-185 targets RhoA and cdc42 expression and inhibits the proliferation potential of colorectal cancer cells. Cancer Lett 2011, 301:151-160. 10.1016/j.canlet.2010.11.009, 21186079.
41. Nagel R1, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA, Agami R. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008, 68:5795-5802. 10.1158/0008-5472.CAN-08-0951, 18632633.
42. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, Röcken C, Ebert MP, Kwok TT, Sung JJ. MiRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009, 101:699-706. 10.1038/sj.bjc.6605195, 2736825, 19638978.
43. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752. 10.1016/j.molcel.2007.05.010, 1939978, 17540599.
44. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007, 104:15472-15477. 10.1073/pnas.0707351104, 2000550, 17875987.
45. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000, 408:307-310. 10.1038/35042675, 11099028.
46. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J, Hermeking H. Inactivation of miR- 34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600. 10.4161/cc.7.16.6533, 18719384.
47. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. Epigenetic silencing of miRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008, 68:4123-4132. 10.1158/0008-5472.CAN-08-0325, 18519671.
48. Cannell IG, Bushell M. Regulation of Myc by miR-34c: a mechanism to prevent genomic instability?. Cell Cycle 2010, 9:2726-2730.
49. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, Heery DM, Gaestel M, Eilers M, Willis AE, Bushell M. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci USA 2010, 107:5375-5380. 10.1073/pnas.0910015107, 2851793, 20212154.